|View printer-friendly version|
|August 03, 2004 5:13 p.m.|
|Teva Reports Record Sales And Net Income In Q2|
Net Sales reach $1.2 billion, Net Income $230 million, and EPS $0.35
Jerusalem, Israel, August 3, 2004 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today reported net income of $230 million which, compared to the second quarter of 2003 that included a one-time gain (after tax) of $ 73 million, represents a 9% increase. Excluding the one-time items in the second quarter of 2003, net income for Q2 2004 increased by 67%. Fully diluted EPS this quarter reached $0.35 which, compared to the second quarter of 2003 that included the one-time gain, decreased by 7% but increased 40% as compared to 2003 second quarter, net of the one-time items.